Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review
Madiha Khan, Lily Park, Stanley Skopit
Abstract
Linear immunoglobulin A (IgA) bullous dermatosis (LABD) is an autoimmune condition with various triggers. Because of the lack of randomized controlled trials on LABD treatment, management options are mostly anecdotal. This paper provides a comprehensive review of treatment options from a literature review of reported treatments to arm clinicians with a guideline for the management of LABD in both pediatric and adult patients as well as those recalcitrant to first-line therapy (dapsone and steroids). We additionally illustrate an algorithm to use for the management of LABD to aid clinicians when faced with unique patient circumstances.
Topics & Concepts
MedicineDapsoneGuidelineIntensive care medicineRandomized controlled trialDermatologyPediatricsSurgeryPathologyAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaUrticaria and Related Conditions